EPCAM and cancer: In our current study, the primary objective was to investigate the occurrence of rare cancer cells based on the specific binding of QDAb for the EpCAM+ and EpCAM− (CD44+ and CD45 +) cell lines in-vitro based peripheral blood mimic sample co-culture models.